Drug – bio-affecting and body treating compositions – Lymphokine
Reexamination Certificate
2007-04-17
2007-04-17
Chan, Christina (Department: 1644)
Drug, bio-affecting and body treating compositions
Lymphokine
C424S184100, C424S537000, C424S561000
Reexamination Certificate
active
09380327
ABSTRACT:
A method of treating an infertility condition in humans or mammals, by exposure of a prospective mother to TGF beta or derivative or analog of TGF beta. The exposure is advantageously in conjunction with one more antigens of a prospective father so that a hyporesponsive immune reaction is mounted to the one or more antigens of the prospective father.
REFERENCES:
patent: 5166190 (1992-11-01), Mather et al.
patent: 5395825 (1995-03-01), Feinberg et al.
patent: WO 91/10445 (1991-07-01), None
patent: WO 95/04931 (1995-02-01), None
Chaouat G, Immunologic Consequences of vaccination against abortion in mice, Mar. 1985, J. Ummunol 134(3): 1594-8.
Toder V, Mouse Model for the Treatment of Immune Pregnancy Los, 1991, American J. Reproductive Immunol 26: 42-46.
Dunker et al, Targeted mutations of transforming growth factor-beta genes reveal important roles in mouse development and adult homeostasis, Dec. 2000, Eur J Biochem 267(24): 6982-8.
Ngo et al, in The Protein Folding Problem and Tertiary Structure Prediction, 1994, Merz, et al., (ed.), Birkhauser, Boston, MA, pp. 433 and 492-495).
Clark et ak, Hum Reprod 9(12): 2270-7, Dec. 1994.
Lyons et al, J Cell Biol 110(4): 1361-7, Apr. 1990.
Harlow et al, in A Laboratory Manual, Cold Spring Harbor Laboratory, p. 61, 1988.
Tuan et al, Connect Tissue Res 34(1): 1-9, 1996.
Grainger et al, Nat Med 1(9):932-7; Sep. 1995.
Anonymous, in World Health Organization Laboratory Manual for the Examination of Human Semen and Semen Cervical Mucus Interaction, Cambridge University Press, NY, pp. 3-11, 1987.
Heidenreich et al, Am J. Reprod Immunol 31(2-3):69-76, Mar.-Apr. 1994.
Martin-Villa et al, Biol Reprod 55(3): 620-9, Sep. 1996.
Ober et al, The Lancet 354: 365-369, Jul. 1999.
Coulam et al, Am J. Reproduc Immunology 32: 55-72, 1994.
Pearson et al, Nature 420: 265-266, Nov. 2002.
Lea et al, Am J. Reprod Immunol 34(1): 52-64, Jul. 1995.
Nocera et al, Am J. Reprod. Immunology 33: 282-291, 1995.
Thomas et al, Am J Reprod. Immunol 6(4): 185-9, Dec. 1984.
Thaler et al, Am J Reprod Immunol 21(3-4): 147-50, Nov.-Dec. 1989.
Prakash et al, Reproductive Immunology 70: 403-412, 1981.
Grainger et al, Nat Mad 1(9): 932-7, Sep. 1995.
Heidenreich et al, Am J Reprod Immunol 31(2-3): 69-76, Mar.-Apr. 1994.
Tremellen et al 2002, www.usnews.com articles 021021.
Robertson 2002, www.adelaide.edu.au/robertsons.
Michel et al.1990 Br.J. Obstet.Gynaecol, V.97, pp. 084-988.
Graham et al., 1994, Exp.Cell Res. V.214, pp. 93-99.
Graham et al., 1992 Biochem Cell Biol. vol. 70, pp. 867-874.
“Suppressed Cell-Mediated Immunity and Monocyte and Natural Killer Cell Activity Following Allogeneic Immunization of Women with Spontaneous Recurrent Abortion”; Grafter et al.,Journal of clinical Immunology, 17(5)m 408-419; 1997.
“Characterization of Latent Transforming Growth Factor-β From Human Seminal Plasma” Nocera et al.,American Journal of Reproductive Immunology33, 282-291, 1995.
“Localization of seminal plasma transforming growth factor-β1 on human spermatozoa: and immunocytochemical study” Chu et al.,Fertility and Sterility66(2), 327-330, 1996.
Clark et al., “Murine Pregnancy Decidua Produces a Unique Immunosuppressive Molecule Related to Transforming Growth Factor β-21”, The Journal of Immunology, vol. 144, 3008-3014, No. 8, Apr. 15, 1990.
Immunity's Pregnant Pause, Nature, Nov. 21, 2002, pp. 265-266, vol. 420.
Gentle Persuasion, New Scientist, Feb. 9, 2002, pp. 32-35.
Anie Philip et al., “Interaction of Transforming Growth Factor-β1 with α2-Macroglobulin”, The Journal of Biological Chemistry, Nov. 25, 1991, pp. 22290-22296, vol. 266, No. 33.
Laiage M. Wakefield et al., “Recombinant Latent Transforming Growth Factor β1 Has a Longer Plasma Half-Life in Rats than Active Transforming Growth Factor β1, and a Different Tissue Distribution”, The Journal of Clinical Investigation, Inc., Dec. 1990, pp. 176-1984, vol. 86.
The Australian Society for Medical Research, South Australian Division, Scientific Meeting, May. 31st, 1996, Abstracts.
Robertson et al., “Granulocyte macrophage colony stimulating factor (GM-CSF) in the murine reproductive tract: stimulation by seminal factors”, Reprod. Fertil. Dev., (1990), 2(4):359-68 (Abstract).
Robertson et al., “Role of high molecular weight seminal vesicle proteins in eliciting the uterine inflammatory response to semen in mice”, Journal of Reproduction and Fertility (1996), 107, 265-277.
The Australian Society for Medical Research, 35thNational Scientific Conference, Nov. 24-27, 1996, Program and Abstracts.
Robertson Sarah Anne
Tremellen Kelton Paul
Belyavaskyi Michail A.
Chan Christina
Proskauer Rose LLP
The University of Adelaide
LandOfFree
Treatment and diagnosis of infertility using TGFβ or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment and diagnosis of infertility using TGFβ or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment and diagnosis of infertility using TGFβ or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3767176